Neuroprotective Properties of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) and its Lipid Ligands

被引:97
|
作者
Fidaleo, Marco [1 ]
Fanelli, Francesca [2 ,3 ]
Ceru, Maria Paola [3 ,4 ]
Moreno, Sandra [3 ]
机构
[1] IRCCS S Lucia Fdn, I-00143 Rome, Italy
[2] Univ Campus Biomed, I-00128 Rome, Italy
[3] Univ Roma Tre, Dept Sci, I-00146 Rome, Italy
[4] Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Coppito, AQ, Italy
关键词
Brain; catalase; fatty acyl-CoA beta-oxidation; lipid signalling; neurodegeneration; neuroprotection; OEA; oxidative stress; PEA; peroxisome proliferator activated receptor; RETINOID-X-RECEPTOR; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; NF-KAPPA-B; INHIBIT INFLAMMATORY RESPONSES; NUCLEAR HORMONE-RECEPTORS; ACID AMIDE HYDROLASE; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; FATTY-ACID;
D O I
10.2174/0929867321666140303143455
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Signalling lipids are known to control a wide array of cellular processes, including cell proliferation, apoptosis, migration, and energy metabolism. Fatty acids and their derivatives, eicosanoids, phosphoinositides, sphingolipids, some cannabinoid-like molecules bind and activate nuclear receptors, including peroxisome proliferator-activated receptors (PPARs). This subfamily of transcription factors comprises three isotypes - PPAR alpha (NR1C1), PPAR beta/delta (NR1C2), PPAR gamma (NR1C3) - which bind to specific DNA response elements, as heterodimers with retinoid X receptors. PPAR activity is modulated by post-translational modifications and cofactors, towards which they show differential affinity. The three PPARs mutually interact, being integrated in a complex system, leading to the concept of a "PPAR triad". Nevertheless, the isotypes also show distinct actions on cellular physiology and partially different tissue, ligand and target gene specificities. In the brain, while the functions of PPAR gamma and its ligands are being thoroughly investigated, the actual and potential roles of PPAR alpha and beta/delta are far from being clarified. PPAR appears especially intriguing, since it is selectively expressed in certain brain areas and neuronal/glial populations, and modulates antioxidant responses, neurotransmission, neuroinflammation, neurogenesis, and glial cell proliferation/differentiation. This receptor and its endogenous ligands, including oleoylethanoloamide (OEA) and palmitoylethanolamide (PEA), are involved in physiological and pathological responses, such as satiety, memory consolidation, and modulation of pain perception. The protective role of PPAR alpha agonists in neurodegenerative diseases and in neuropsychiatric disorders makes manipulation of this pathway highly attractive as therapeutic strategy for neuropathological conditions. In this review, we focus on the pleiotropic functions of PPAR alpha and its lipid ligands in the nervous tissue, devoting special attention to neuroprotection.
引用
收藏
页码:2803 / 2821
页数:19
相关论文
共 50 条
  • [41] Induction of the expression of the peroxisome proliferator-activated receptor alpha (PPARα) by clofibrate in jerboa tissues
    Amsaguine-Safir, S
    Bianchi, A
    Collet, P
    Huin-Schohn, C
    Jeanvoine, A
    Bécuwe, P
    Krémarik-Bouillaud, P
    Domenjoud, L
    Keller, JM
    Schohn, H
    Dauça, M
    MICROSCOPY RESEARCH AND TECHNIQUE, 2003, 61 (02) : 185 - 190
  • [42] Pancreatic islet response to hyperglycemia is dependent on peroxisome proliferator-activated receptor alpha (PPARα)
    Bihan, H
    Rouault, C
    Reach, G
    Poitout, V
    Staels, B
    Guerre-Millo, M
    FEBS LETTERS, 2005, 579 (11) : 2284 - 2288
  • [43] Implications of a peroxisome proliferator-activated receptor alpha (PPARα) ligand clofibrate in breast cancer
    Chandran, Karthic
    Goswami, Sudeshna
    Sharma-Walia, Neelam
    ONCOTARGET, 2016, 7 (13) : 15577 - 15599
  • [44] Peroxisome Proliferator-Activated Receptor Alpha (PPARα), Beta (PPARβ), and Gamma (PPARγ) Expression in Human Fetal Tissues
    Abbott, B. D.
    Wood, C. R.
    Watkins, A. M.
    Das, K. P.
    Lau, C. S.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2010, 88 (05) : 352 - 352
  • [45] Role of peroxisome proliferator-activated receptor (PPAR)-α gene in Dyslipidemia
    Rashid, Amir
    Jafar, Sadaf
    Yaqub, Raja Khalid
    RAWAL MEDICAL JOURNAL, 2020, 45 (01): : 54 - 57
  • [46] Differential splicing of the human peroxisome proliferator-activated receptor, PPARβ/δ
    Su, Shengzhong
    Omiecinski, Curtis J.
    FASEB JOURNAL, 2007, 21 (05): : A419 - A419
  • [47] Peroxisome proliferator-activated receptor (PPAR) modulators: Diabetes and beyond
    Jones, AB
    MEDICINAL RESEARCH REVIEWS, 2001, 21 (06) : 540 - 552
  • [48] Natural Peroxisome Proliferator-Activated Receptor γ (PPARγ) Activators for Diabetes
    Abdallah, Hossam M.
    El Dine, Riham Salah
    Mohamed, Gamal A.
    Ibrahim, Sabrin R. M.
    Shehata, Ibrahim A.
    El-Halawany, Ali M.
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2020, 26 : 28 - 44
  • [49] Peroxisome Proliferator-Activated Receptor a in Lipid Metabolism and Atherosclerosis
    Yu, Xiao-Hua
    Zheng, Xi-Long
    Tang, Chao-Ke
    ADVANCES IN CLINICAL CHEMISTRY, VOL 71, 2015, 71 : 171 - 203
  • [50] Peroxisome proliferator-activated receptor alpha and the ketogenic diet
    Cullingford, Tim
    EPILEPSIA, 2008, 49 : 70 - 72